X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5877) 5877
Publication (386) 386
Book Review (101) 101
Book / eBook (24) 24
Book Chapter (24) 24
Newsletter (12) 12
Magazine Article (9) 9
Conference Proceeding (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5424) 5424
male (3519) 3519
female (3441) 3441
middle aged (2954) 2954
thrombolytic therapy (2886) 2886
aged (2798) 2798
index medicus (2641) 2641
treatment outcome (2266) 2266
thrombolytic therapy - methods (1799) 1799
thrombolytic therapy - adverse effects (1708) 1708
cardiac & cardiovascular systems (1511) 1511
peripheral vascular disease (1357) 1357
risk factors (1286) 1286
adult (1276) 1276
thrombolysis (1263) 1263
fibrinolytic agents - therapeutic use (1251) 1251
time factors (1248) 1248
stroke (1147) 1147
aged, 80 and over (1102) 1102
fibrinolytic agents - adverse effects (1090) 1090
retrospective studies (1069) 1069
fibrinolytic agents - administration & dosage (1006) 1006
tissue plasminogen activator - therapeutic use (923) 923
mortality (885) 885
clinical neurology (875) 875
stroke - drug therapy (861) 861
care and treatment (832) 832
therapy (826) 826
tissue plasminogen activator - adverse effects (816) 816
myocardial infarction - drug therapy (814) 814
tissue plasminogen activator - administration & dosage (772) 772
myocardial infarction - therapy (770) 770
prospective studies (673) 673
surgery (651) 651
tissue-plasminogen activator (622) 622
heart attack (621) 621
acute myocardial-infarction (603) 603
myocardial infarction - mortality (601) 601
management (600) 600
acute ischemic-stroke (588) 588
follow-up studies (572) 572
prognosis (564) 564
acute disease (537) 537
ischemia (524) 524
trial (521) 521
thrombosis (520) 520
drug therapy (498) 498
brain ischemia - drug therapy (495) 495
heart attacks (494) 494
tissue plasminogen activator (489) 489
angioplasty (488) 488
electrocardiography (467) 467
risk assessment (459) 459
cardiology (456) 456
health aspects (448) 448
alteplase (444) 444
thrombolytic drugs (442) 442
neurosciences (441) 441
analysis (426) 426
cardiovascular (413) 413
reperfusion (412) 412
anticoagulants - therapeutic use (409) 409
medicine, general & internal (407) 407
recurrence (398) 398
risk (388) 388
myocardial infarction (379) 379
coronary angiography (378) 378
hematology (373) 373
stents (366) 366
medicine & public health (364) 364
hemorrhage (356) 356
neurology (356) 356
infusions, intravenous (354) 354
animals (351) 351
abridged index medicus (348) 348
anticoagulants (346) 346
angioplasty, balloon, coronary (345) 345
research (338) 338
tissue-plasminogen-activator (338) 338
stroke - therapy (328) 328
outcomes (321) 321
primary angioplasty (319) 319
predictive value of tests (315) 315
myocardial infarction - physiopathology (313) 313
patient outcomes (312) 312
tomography, x-ray computed (309) 309
radiology, nuclear medicine & medical imaging (306) 306
thrombosis - drug therapy (305) 305
hemorrhage - chemically induced (304) 304
cardiac patients (303) 303
percutaneous coronary intervention (303) 303
streptokinase (298) 298
severity of illness index (294) 294
combined modality therapy (292) 292
usage (291) 291
intravenous thrombolysis (287) 287
randomized controlled trials as topic (286) 286
stroke - diagnosis (285) 285
fibrinolysis (283) 283
logistic models (283) 283
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5705) 5705
German (76) 76
French (36) 36
Russian (27) 27
Spanish (21) 21
Italian (10) 10
Norwegian (9) 9
Hungarian (8) 8
Japanese (8) 8
Chinese (7) 7
Polish (5) 5
Portuguese (5) 5
Swedish (5) 5
Danish (4) 4
Czech (3) 3
Dutch (3) 3
Serbian (2) 2
Turkish (2) 2
Hebrew (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 07/2003, Volume 108, Issue 2, pp. 135 - 142
Background-The combination of a single-bolus fibrinolytic and a low-molecular-weight heparin may facilitate prehospital reperfusion and further improve... 
Myocardial infarction | Reperfusion | Heparin | Fibrinolysis | Hemorrhage | MORTALITY | RETEPLASE | CARDIAC & CARDIOVASCULAR SYSTEMS | TISSUE-PLASMINOGEN ACTIVATOR | myocardial infarction | fibrinolysis | heparin | THERAPY | PERIPHERAL VASCULAR DISEASE | REOCCLUSION | reperfusion | INTERVENTION | hemorrhage | Injections, Intravenous | Humans | Middle Aged | Heparin - therapeutic use | Male | Risk | Tissue Plasminogen Activator - therapeutic use | Enoxaparin - therapeutic use | Heparin - adverse effects | Enoxaparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Time Factors | Hemorrhage - etiology | Injections, Subcutaneous | Thrombolytic Therapy - methods | Female | Safety | Drug Therapy, Combination | Treatment Outcome | Emergency Medical Services - statistics & numerical data | Myocardial Infarction - drug therapy | Survival Analysis | Aged | Emergency Medical Services - methods | Thrombolytic Therapy - adverse effects | Cohort Studies | Hemorrhage/etiology | Enoxaparin/adverse effects/therapeutic use | Injections; Intravenous | Emergency Medical Services/methods/statistics & numerical data | Myocardial Infarction/drug therapy | Injections; Subcutaneous | Thrombolytic Therapy/adverse effects/methods | Drug Therapy; Combination | Research Support; Non-U.S. Gov't | Heparin/adverse effects/therapeutic use | Tissue Plasminogen Activator/adverse effects/therapeutic use
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2013, Volume 12, Issue 12, p. CD001099
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2014, Volume 2014, Issue 1
Journal Article
Eur Heart J, ISSN 1522-9645, 2008, Volume 29, Issue 23, p. 2909
Journal Article
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, ISSN 1469-493X, 2004, Issue 3
Background Standard treatment for deep vein thrombosis (DVT) aims to reduce immediate complications. Use of thrombolysis or clot dissolving drugs could reduce... 
Thrombolytic Therapy [adverse effects; methods] | MEDICINE, GENERAL & INTERNAL | Venous Thrombosis [drug therapy] | Humans | Randomized Controlled Trials as Topic
Journal Article
Stroke, ISSN 0039-2499, 02/2010, Volume 41, Issue 2, pp. 280 - 287
Background and Purpose-Ultrasound-enhanced thrombolysis is a promising new approach to facilitate reperfusion therapies for acute ischemic stroke. So far, 3... 
Transcranial color-coded duplex | Stroke | Tissue plasminogen activator | Sonothrombolysis | Transcranial Doppler | Ultrasound-enhancedthrombolysis | sonothrombolysis | tissue plasminogen activator | TISSUE-PLASMINOGEN ACTIVATOR | HEMORRHAGE | stroke | CLINICAL NEUROLOGY | transcranial color-coded duplex | TRIAL | FIBRINOLYSIS | transcranial Doppler | ACUTE ISCHEMIC-STROKE | PERIPHERAL VASCULAR DISEASE | INTRAVENOUS MICROBUBBLES | TRANSCRANIAL ULTRASOUND | CLOT LYSIS | ultrasound-enhancedthrombolysis | LOW-FREQUENCY ULTRASOUND | Humans | Middle Aged | Male | Intracranial Thrombosis - therapy | Tissue Plasminogen Activator - adverse effects | Ultrasonography, Doppler, Transcranial - methods | Fibrinolytic Agents - adverse effects | Thrombolytic Therapy - methods | Aged, 80 and over | Female | Combined Modality Therapy - statistics & numerical data | Ultrasonic Therapy - adverse effects | Ultrasonography, Doppler, Transcranial - adverse effects | Intracranial Thrombosis - physiopathology | Randomized Controlled Trials as Topic - statistics & numerical data | Brain Ischemia - therapy | Thrombolytic Therapy - statistics & numerical data | Tissue Plasminogen Activator - administration & dosage | Treatment Outcome | Brain Ischemia - physiopathology | Combined Modality Therapy - adverse effects | Ultrasonic Therapy - methods | Aged | Combined Modality Therapy - methods | Fibrinolytic Agents - administration & dosage | Ultrasonic Therapy - statistics & numerical data | Ultrasonography, Doppler, Transcranial - statistics & numerical data | Thrombolytic Therapy - adverse effects | Brain Ischemia - diagnostic imaging | Intracranial Thrombosis - diagnostic imaging
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 15, pp. 1379 - 1387
Reperfusion strategies with fibrinolysis or primary PCI were compared in this trial involving patients with ST-segment elevation myocardial infarction (STEMI).... 
MORTALITY | SURVIVAL | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | RANDOMIZED-TRIAL | DELAYS | REPERFUSION STRATEGY | Recurrence | Myocardial Infarction - mortality | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Tissue Plasminogen Activator - therapeutic use | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Angioplasty, Balloon, Coronary | Heart Failure - prevention & control | Fibrinolytic Agents - adverse effects | Myocardial Infarction - therapy | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy - methods | Ticlopidine - adverse effects | Electrocardiography | Female | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Time-to-Treatment | Intracranial Hemorrhages - etiology | Kaplan-Meier Estimate | Ticlopidine - analogs & derivatives | Coronary Angiography | Myocardial Infarction - drug therapy | Aged | Drugs | Dose-response relationship (Biochemistry) | Usage | Care and treatment | Angiography | Angioplasty | Patient outcomes | Product/Service Evaluations | Thrombolytic drugs | Heart attack | Dosage and administration | Diagnosis | Drug therapy | Myocardial infarction | Anticoagulants | Fibrin | Heart attacks | Medical imaging | Reperfusion | Clopidogrel | Congestive heart failure | Fibrinolysis | Bleeding
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2018, Volume 379, Issue 7, pp. 611 - 622
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9834, pp. 2352 - 2363
Journal Article